Digitalis Ventures — Full Portfolio

Judo Bio develops oligonucleotide medicines, including ligand-siRNA conjugate drugs, delivered to the kidney for systemic and renal diseases using its STRIKE (Selectively Targeting RNA Into KidnEy) platform.

BiotechHealthtechCambridge, US

AFAndrew Fraley(Judo Bio Co-Founder)inASAlfica SehgalinOCOMMER CHOHAN(Executive Officer)inJAMES JEFFREY GOATER(Executive Officer, Director)SRSimon Read(Executive Chair and Acting CEO)inWHWilliam Ho

Co-investorsATAtlas VentureDRDroia VenturesTHThe Column GroupYKYK Bioventures

Gallant develops regenerative medicine therapies for veterinary care, bringing treatments from laboratory research into clinical practice for pets.

BiotechHealthtechMedical DevicesSan Diego, US

Aaron Hirschhorn(Founder)LBLinda Black(Chief Executive Officer; founding team member)inDavis Brimer(Executive Officer, Director)Beau Becker(Head of Strategic Operations & People Effectiveness; founding team member)in

BoardTBTeymour Boutros-Ghali(Director)inValentine Williams(DVM, MS, Diplomate ACVS)

Board seatMUMisti Ushio· per SEC Form D

Co-investorsALAlpha EdisonALAlumni VenturesBABaroda VenturesBLBling CapitalBOBold Capital PartnersEXExpansion Venture Capital+3 more

The page announces the launch of a new fintech arm called CapForce.

BiotechFintechGaithersburg, US

Evan Jones(Executive Officer, Director)Vadim Sapiro(Executive Officer)inC. Eric Winzer(Executive Officer)DHDavid Hoekzema(Executive Officer)inTerry Walker(Executive Officer)C. Douglas White(Executive Officer, Director)

Board seatMUMisti Ushio· per SEC Form D · $1.5M raise · filed Jun 2017

Co-investorsCRCross Creek AdvisorsINIn-Q-TelHIHighland Capital Partners

CE Brands, Inc. designs, manufactures, and distributes smart consumer electronic products, including connected health wearables and health analytics software, in partnership with manufacturers, brands, and retailers.

ConsumerHardwareHealthtechIoTNew York, US

EOEran Ofir(Executive Officer, Director)inCHCharles Herman(Executive Officer, Director)in

BoardMeir Akkerman(Director)Andrew Gianonne(Director)Christopher Geczy(Director)

Board seatDTDrew TaylorABAmit Bansal· per SEC Form D

Co-investorsEAEast Post Road VenturesKLKleiner Perkins

Alcea Tx develops an immune-tolerance restoration technology that targets Treg cells to reset immune homeostasis in the lungs, with a lead asset aimed at asthma and pulmonary viral infections such as influenza and SARS-CoV2.

BiotechHealthtech

Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development.

BiotechDigital HealthMedical DevicesVancouver, CA

FBFrançois Bénard(Founder)KLKuo-Shyan Lin(Founder)DPDavid Perrin(Founder)

Co-investorsANAndreessen HorowitzASAscenta CapitalDEDelos CapitalFRFrazier Life SciencesGEGeneral CatalystLILightspeed Venture Partners+9 more

Alterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic.

AI & Machine LearningBiotechDeep TechSan Diego, US

EAEric A. Murphy(Executive Officer, Director, Promoter)inRyan B. Corcoran(Director, Promoter)Richard Heyman(Founder)

BoardTSThilo Schroeder(Director)inCGCarl Gordon(Director)inAGArjun Goyal(Director)in

Co-investorsCACanaan PartnersNENextech InvestOROrbiMedVIVida VenturesNVNVIDIA

Ansel Health provides health benefit solutions focused on cost-sharing and coverage for unexpected medical bills for employer groups and individuals.

ConsumerHealthtechInsurTechHoboken, US

VGVeer Gidwaney(CEO)inATAmanda Turcotte(Executive Officer)in

BoardColin Beire(Director)Elizabeth Bierbower(Director)

Co-investors50500 GlobalALAlumni VenturesCICity LightFOFounder CollectivePLPlug and Play VenturesBRBrewer Lane Ventures+3 more

Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages.

BiotechHealthtechMedical DevicesMunich, DE

Evis Hursever(Executive Officer)Wesley McConnell(Executive Officer)inMichael Stella(Executive Officer, Director)William Hawkins(Executive Officer)

BoardMichael Beecham(Director)Andrew Kozlov(Director)

Co-investorsCACathay HealthDCDCVC (Data Collective)MOMonograph Capital Partners4B4BIO Capital

Biotechnology company developing immunomodulators using a HALOS nanotechnology platform for chronic inflammation.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

MTMichael Tolentino(Executive Officer, Director)inMAMohamed A. Genead(Chairman & CEO)inDavid Callanan(Executive Officer)inDerek Kunimoto(Executive Officer)inJNJeffrey Nau(Chief Executive Officer)inTSTarek S. Hassan(Chief Development Officer)in

Co-investorsJEJeito CapitalLOLongitude CapitalCACatalio Capital Management, LPOROrbiMedAVAvoro Capital AdvisorsOMOmega Funds

B5 Genomics offers the Benthic Analysis Platform, software that converts microarray and sequencing data (short-read and long-read) into high-resolution genotyping and variant calls for complex genomic regions such as HLA, KIR, and the MHC.

AI & Machine LearningBiotechHealthtech

Bonum Therapeutics develops antibody-controlled protein therapeutics that remain inactive until bound to their target, using a sensor-domain mechanism to deliver regulated, targeted activity.

BiotechHealthtechSeattle, US

JMJohn Mulligan(Executive Officer, Director, Promoter)inNPNeela Patel(Executive Officer)inDHDiane Hollenbaugh(Executive Officer)in

BoardSBSamuel Bjork(Director)inMSMonique Schiersing(Director)inJMJohn McKearn(Director)in

Co-investorsRIRiverVest Venture PartnersRORoche Venture FundVIVivo Capital3X3x5 PartnersCOCodon Capital

Buddy provides a digital commerce platform for insurance that converts product rules, pricing, and workflows into structured data and deploys them as modern buying experiences across multiple channels.

AI & Machine LearningFintechInsurTechSaaS

CMCharles Merritt(Co-Founder, CEO)inDVDavid Vogeleer(Co-Founder, CTO)in

Co-investorsABAbstraction CapitalNENewlin Ventures

Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment.

ConsumerDigital HealthHealthtechMedical Devices

NGNick Greenfield(Founder)in

Co-investorsA-A-Rod CorpAVAverin CapitalBEBessemer Venture PartnersBEBeyond CapitalF-F-Prime CapitalFAFantail Ventures+9 more

Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization.

BiotechDigital HealthHealthtechMedical DevicesBurlington, US

MEMichael E. Mendelsohn(Founder and Chief Strategy Officer)in

Co-investorsBABain CapitalASAscenta CapitalDEDelos CapitalNENew Enterprise Associates (NEA)BABain Capital Life SciencesBABain Capital Tech Opportunities+4 more

CareDox (operating as SchoolCare) provides a digital health record platform for K-12 school nurse offices that manages immunizations, chronic disease information, and student health compliance reporting.

Digital HealthEdTechHealthtechForest Hills, US

HKHesky Kutscher(Executive Officer, Director)in

BoardGreg Goff(Director)Eyal Niv(Director)

Co-investorsKIKima Ventures7W7wire VenturesFIFirst Round CapitalPRProlog VenturesSTStartUp HealthTETEXO Ventures+1 more

Clasp connects employers with healthcare students before graduation and ties student loan repayment to employment, addressing both clinical workforce shortages and student debt.

EdTechFintechHealthtechHR TechBoston, US

TMTess Michaels(Founder)in

Co-investorsCRCrosslink CapitalGSGSV VenturesJUJuvo VenturesBABase10 PartnersBLBlumberg CapitalGRGradient Ventures+1 more

Clasp provides API-based infrastructure and automation for employee health benefits administration, handling quoting, group setup, open enrollment, carrier feeds, and ACA/COBRA compliance.

FintechInsurTechSaaS

Co-investorsCOConversion CapitalTETerrainCRCrosslink Capital

Code Ocean is a cloud computational research platform for reproducible code, data and environments in science.

New York, US

Simon Adar(Founder)in

BoardSTScott Tobin(Director)inJRJoshua Ruch(Director)inMarty Kahn(Director)

Co-investorsBABattery VenturesBEBeaconsfield CapitalGAGaingelsKRKreos CapitalM1M12 (Microsoft's Venture Fund)OLOlima Ventures+2 more

Eden Brew develops food and supplementation products designed to deliver nutrition in natural forms that align with how the human body processes nutrients, with a focus on sustainable scaling and long-term health support.

BiotechDeep TechFoodTechHealthtechImpact & Social Good

JFJim Fader(Founder)in

Co-investorsBRBreakthrough VictoriaMAMain Sequence VenturesPOPossible VenturesRARadar Ventures

Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.

BiotechDeep TechSan Carlos, US

MHMatthew Hill(Executive Officer, Director)in

BoardPZPeter Zhou(Director)inCMCain McClary(Director)inJonathan Sheena(Director)in

Co-investorsACACVC PartnersANAndreessen HorowitzINIn-Q-TelRARaptor GroupTRTriatomic CapitalAMAME Cloud Ventures+1 more

Elemental Machines provides an IoT platform combining hardware, software, and data science to monitor lab and manufacturing equipment, environments, and workflows in real time.

AI & Machine LearningBiotechHardwareHealthtechIoTSaaSCambridge, US

SISridhar Iyengar(Executive Officer, Director)inUna Ryan(Director)JKJeff Klemens(Director)inSVSonny Vu(Director)in

BoardGTGaurav Tewari(Director)inRDRobert Davoli(Director)in

Co-investorsGUGutbrain VenturesHEHemisphere Ventures LLCJOJoint EffectsOMOmega Venture PartnersSASageview CapitalTATau Ventures+2 more

Sridhar Iyengar(Founder)

Co-investorsHEHealthtech CapitalGUGutbrain VenturesKDKdT Ventures

Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.

BiotechMedical DevicesSan Mateo, US

ALAnn Lee-Karlon(Executive Officer, Director)inMitchell Mutz(Executive Officer, Director)James Wells(Director)

BoardSBSamuel Bjork(Director)inACAlexandra Cantley(Director)inSMSeiji Miyahara(Director)in

Co-investorsAVAvego BioScience CapitalGVGV (Google Ventures)MIMission BiocapitalNONovartis Venture FundRORoche Venture FundSASamsara BioCapital+4 more

Expressable provides speech therapy services using research-based techniques with a focus on family engagement and accessibility.

Digital HealthHealthtechSaaSAustin, US

NBNicholas Barbara(Executive Officer, Director)inLeanne Sherred(President and Chief Clinical Officer)inBenjamin Pincus(Executive Officer)inSpencer Magloff(Executive Officer)inRyan Hinojosa(Executive Officer)

Co-investorsF-F-Prime CapitalLELerer HippeauNENextView VenturesHAHarbourVest Partners (Canada)

Co-investorsNONoro-Moseley PartnersSUSustainVC

Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.

HealthtechMiami Lakes, US

CDCarlos D. Bustamante(Executive Officer, Director)inArthur Polk(Executive Officer)Alexander Ioannidis(Director)

BoardWAWale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)

Co-investorsCECEI VenturesCICitta CapitalF-F-Prime CapitalFOFounder CollectiveFUFunction VenturesHEHelios Digital Ventures+4 more

Girihlet develops a diagnostic tool to monitor autoimmune treatments, helping patients and the doctors treating them select the most effective therapies.

BiotechHealthtechBrooklyn, US

Ravi Sachidananadam(Executive Officer, Director)Anitha Jayaprakash(Executive Officer, Director)

Co-investorsSOSOSV

Portfolio company acquired by Roche.

BiotechSeattle, US

JMJohn Mulligan(Executive Officer, Director, Promoter)inMitchell Mutz(Director)Nicholas Walrod(Director)

BoardJMJohn McKearn(Director)inKarl Handelsman(Director)

Co-investorsRIRiverVest Venture Partners3X3x5 PartnersCOCodon CapitalRORoche Venture Fund

GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.

BiotechDeep TechHealthtechCambridge, US

Daniel J Mandell(Chief Executive Officer)TLTracey Lodie(Executive Officer)inChristopher Gregg(Director)

BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)

Co-investorsLELeaps by BayerREREDMILEALAlumni VenturesDRDreamers VCRIRising TideACAccess Industries+3 more

Helm Health provides benefit design and member engagement tools for health plans, incorporating cost and quality data into coverage decisions, bundling claims into transparent pricing, and offering provider search functionality.

Enterprise SoftwareHealthtechInsurTechSan Francisco, US

Co-investors.4.406 Ventures3C3CC | Third Culture CapitalFLFlare Capital PartnersHEHeadwater VenturesSESemperVirens Venture CapitalINInitialized Capital

Kenzen develops AI-powered occupational health and safety systems that integrate predictive analytics and real-time monitoring to reduce workplace injuries and improve workforce performance.

AI & Machine LearningEnterprise SoftwareHealthtechHR TechSan Francisco, US

Sonia Sousa(Executive Officer, Director)

BoardJake Ireland(Director)Lorenzo Thione(Director)Steven Pecko(Director)

Co-investorsEMEmpire AngelsEVEvolution VC PartnersGAGaingelsKCKCRise FundRORoyal Street Ventures Management Company, LlcSASand Hill Angels+2 more

Kingdom Superculture develops functional health ingredients derived from natural microbes, targeting consumers seeking effective nutritional and health products.

BiotechConsumerFoodTechHealthtechNew MaterialsWellness & FitnessNew York City, US

KDKendall Dabaghi(Founder)inRSRavi Sheth(Founder)inTom Blazejewski(Senior Machine Learning Scientist)Austin Kane(Bizops Associate)Peter Stein(Senior Data Engineer)

Co-investors4D4DX VenturesFOFour Acres CapitalPIPioneerSHShine CapitalSUSupernode VenturesVAValor Equity Partners+25 more

Discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases.

BiotechCambridge, US

Andre Turenne(Executive Officer, Director)in

BoardJHJason Hafler(Director)inBruce Booth(Director)Daniel Becker(Director)

Co-investorsACAccess BiotechnologySASanofi VenturesACAccess IndustriesALAlexandriaATAtlas Venture

Matchpoint Therapeutics is a drug discovery company developing precision small molecule covalent medicines to treat immune and inflammatory diseases.

AI & Machine LearningBiotechDeep Tech

Andre TurenneJared Cumming(PhD)Christopher HrenThomas Durand-Reville(PhD)Wei Li(MD)Paola Castaldi(PhD)

Co-investorsATAtlas VentureSASanofi Ventures

Subscription e-commerce platform for pet owners in China.

Co-investorsCOCompanion FundDCDCM VenturesDCDCMFJFJ LabsSESeek VenturesTETekton Ventures+1 more

Centennial, US

Dennis J. Chmiel(Executive Officer, Director)inJen Hagness(Executive Officer, Director)inNancy A. Willerton(Executive Officer, Director)Dennis J. Chmiel Jr.(Executive Officer, Director)

BoardCindy Cole(Director)Jeremy L. Friese(Director)

Native Pet makes veterinarian-developed nutritional supplements for dogs, including chews, powders, and bone broths that target digestion, joints, skin and coat, calming, and bladder health.

ConsumerDirect to ConsumerWellness & FitnessSt Louis, US

Patrick M Barron(Manager / Member)

Co-investorsCOCompanion FundR/R/GA VenturesSESelva VenturesCACAVU Consumer Partners

Neion Bio operates a biomanufacturing platform that re-engineers eggs into living bioreactors using genetic engineering and stem cell biology to produce biological molecules such as monoclonal antibodies, enzymes, fusion proteins, peptides, and cytokines.

Advanced ManufacturingBiotechDeep TechNew York, US

SLSam Levin(Founder)inDKDimi Kellari(Founder)in

Co-investorsCACaffeinated CapitalCLClocktower VenturesHAHAWKTAILBABasis Set VenturesENEnsemble VCHAHaystack+1 more

Nuvig Therapeutics develops immune-modulating medicines for autoimmune diseases by harnessing endogenous regulatory mechanisms to resolve immune dysregulation.

BiotechHealthtechMedical Devices

Pamela Conley(Founder)in

Co-investorsB B Capital GroupB4B4 CapitalGLGlobal BioAccess FundMIMission BiocapitalSASanofi VenturesNONorwest Venture Partners

Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function.

BiotechLongevity

Co-investorsSASanofi VenturesABabrdn plcALAlexandriaB B CapitalGLGlobal BioAccess FundLELeaps by Bayer+4 more

Omni makes electric scooter attachments that connect to wheelchairs, letting wheelchair users travel on urban and off-road terrain; the company states 95% of wheelchairs are compatible with its devices.

HardwareHealthtechMobility & Transportation

Co-investors5050 PartnersCRCraft VenturesFIFirst Round CapitalGVGV (Google Ventures)ICICONIQICICONIQ Growth+6 more

Omni is a non-custodial multi-chain crypto wallet that lets users store, bridge, and swap tokens across multiple blockchains, import wallets from MetaMask, Keplr, and Phantom, build custom portfolios, and buy crypto with a credit card.

Crypto & Web3Fintech

Serafin Lion Engel(Founder)

Co-investorsFIFigmentFLFlori VenturesCRCraft VenturesEMEmerge VenturesFIFirst Round CapitalGVGV (Google Ventures)+11 more

Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making.

AI & Machine LearningBiotechDigital HealthSan Carlos, US

ANAkshay Nanduri(Founder)inSalmaan Ahmed(Executive Officer)Jonathan Fleming(Director)

Co-investors51515 VenturesLILifeX VenturesBLBlue Venture FundsKDKdT Ventures

Novel antibody-based therapeutics platform for animal health.

Co-investorsCACambridge Innovation CapitalCOCompanion FundPAParkwalk AdvisorsVCVCapital

Positive Development provides autism therapy and developmental care services for neurodivergent children and their families.

Digital HealthHealthtechMedical DevicesMental HealthMclean, US

MSMike Suiters(Executive Officer, Director)inNWNick Whitehead(Director)in

BoardASAdam Seabrook(Director)inDaniel Gebremedhin(Director)JBJohn Banta(Director)inBFBrenton Fargnoli(Director)in

Co-investorsALAlleyCorpAMaMoonB B Capital GroupB4B4 CapitalFLFlare Capital PartnersLILifeforce Capital+3 more

Protego provides chargeback management software that automates dispute processes and tracks chargebacks in real time to help merchants identify patterns in fraudulent activity and recover revenue.

CybersecurityEnterprise SoftwareSaaSBogotá, CO

PRPablo Rojas(Founder)inRafael Casabianca

Co-investorsNONovartis Venture FundY Y CombinatorDRDroia VenturesFOForbionGLGlilot Capital PartnersGLGlobal Founders Capital+7 more

Protego Bio is a biotech company developing first-in-class therapies for protein misfolding diseases, including its lead candidate PROT-001 for AL amyloidosis, based on research into pharmacological chaperones.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Diego, US

BJBrent J. Warner(Executive Officer, Director)inXIN JIANG(President & CEO)inHANK MICHAEL PETRASSI(Executive Officer)JEFFERY KELLY(Director)

BoardTIM LOHOFF(Director)Edward Hurwitz(Director)

Co-investorsDRDroia VenturesNONovartis Venture FundFOForbionLILightspeed Venture PartnersMPMPM BioImpactVIVida Ventures+1 more

Reema Health provides a personalized, community-based care model that connects people to health care and social support services in their local communities.

Digital HealthHealthtechImpact & Social GoodMental HealthMinneapolis, US

JLJustin Ley(CEO)inMatt(Chief Product Officer)

BoardHCHelen Ciesielski(Director)inMatthew Swanson(Director)EHEllen Herlacher(Director)inAmon Anderson(Director)

Co-investorsGRGROOVE CAPITALHCHC9 VenturesHEHeadwater VenturesLRLRVHealthMAMaC Venture CapitalMAMatchstick Ventures+3 more

Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.

BiotechHealthtechLongevitySan Diego, US

NDNoah Davidsohn(CSO, Co-Founder)inDODaniel Oliver(CEO, Co-Founder)inGCGeorge Church(Co-Founder and SAB)DADeborah Ascheim(Chief Medical Officer)in

BoardDZDavid Zhu(Director)in

Co-investorsCOCompanion FundCOConnecticut InnovationsGAGaingelsKEKendall Capital PartnersLILifespan Vision VenturesVCVCapital+1 more

SchoolCare provides a healthcare platform focused on improving health services for children, serving schools, parents, and payers.

Digital HealthEdTechHealthtechSaaSNew York, US

Co-investors7W7wire VenturesCOCorewell Health VenturesWEWestern Technology InvestmentCHCherre

Scout Bio developed biotechnology therapies for pets, including a pipeline of monoclonal antibodies and gene therapy programs targeting chronic diseases in companion animals.

AgTechBiotechDeep TechHealthtechPhiladelphia, US

MHMark Hefferman(Executive Officer, Director)

BoardAKAditya Kohli(Director)inTadataka Yamada(Director)PHPatrick Heron(Director)inCCCindy Cole(Director)inNancy Hong(Director)

Co-investorsCOCompanion FundCOCorrelation VenturesFRFrazier Life SciencesRIRiverVest Venture Partners

Scratch Pay offers point-of-payment patient financing that lets clients of veterinary practices apply for loans and receive instant decisions, with practices paid up front via ACH.

ConsumerFintechHealthtechLos Angeles, US

CCaleb(Founder/President)JKJohn Keatley(Founder)inCaleb Morse(Founder)

Co-investorsARArgonautic VenturesCOCompanion FundFJFJ LabsNONorwest Venture PartnersSTStruck CapitalSWSWS Venture Capital+1 more

BiotechWaltham, US

Ellen E. Sheets(Executive Officer, Director)in

BoardCarl M. Berke(Director)inNancy Hong(Director)in

Co-investorsBOBold Capital PartnersRIRiverVest Venture PartnersKDKdT Ventures

Smalls produces fresh, gently cooked cat food made to resemble home-prepared meals, differentiating itself from conventional pet food manufacturers by using minimal processing.

Direct to ConsumerFoodTech

MMMatthew Michaelson(Founder)inCalvin Bohn(Founder)Matt Michaelson(Founder)

Co-investorsCOCompanion FundEAEastward Capital PartnersEVEvolution VC PartnersFOFounder CollectiveGAGaingelsGEGeneral Mills+9 more

Switch Therapeutics develops RNA interference (RNAi) therapeutic applications targeting central nervous system diseases, leveraging research from Caltech, Harvard Medical School, and City of Hope.

AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US

Si-Ping Han(Secretary)inDeepshikha Datta(Chief Executive Officer and President)

BoardKevin Zhang(Director)Alicia Irurzun-Lafitte(Director)inDMDylan Morris(Director)in

Co-investorsBOBold Capital PartnersCRCRV (Charles River Ventures)DODolby Family VenturesFRFREEFLOWGLGlobal BrainONOno Venture Investment, Inc.+3 more

T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, GB

Co-investorsCACambridge Innovation CapitalF-F-Prime CapitalSASanofi VenturesSOSofinnova PartnersBUBusiness Growth FundUNUniversity of Cambridge Enterprise

Tenvie is a clinical-stage biopharmaceutical company developing small molecule and biologic therapeutics for neurological and peripheral diseases.

BiotechMedical Devices

TETony Estrada(President & Chief Executive Officer; co-founder)in

Co-investorsARARCH Venture PartnersF-F-Prime CapitalBABain Capital Life SciencesFOForbionMUMubadala Capital

Terray is a drug discovery company that combines proprietary hardware, large-scale experimental datasets, and AI through its EMMI platform to design small molecule medicines.

AI & Machine LearningBiotechDeep TechPasadena, US

EBEli Berlin(Founder)inJacob Berlin, Ph.D.(Chief Executive Officer)Jacob Berlin(Founder)Jacob Berlin Eli Berlin(Founder)Nathan Collins(Founder)

BoardCPChris Picardoin

Co-investorsDEDeviation CapitalGAGaingelsMAMadrona Venture GroupMAMana VenturesNVNVIDIASUSummit Peak Investments+6 more

Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases.

BiotechDeep TechBoston, US

WLWayne Lencer(Founder)HGHunter Goble(Founder)inJWJustin Wolfe(Founder)inWilliam Hunter Goble(Executive Officer, Director)Phil Grayeski(Director)

Co-investorsPEPear VCPOPortal InnovationsTATau VenturesKDKdT VenturesTATAU VenturesXOXora Innovation Pte Ltd

Travv develops AI-powered veterinary diagnostics, including digital pathology tools for the animal health industry.

AI & Machine LearningBiotechCloud ComputingHealthtech

DWDerick Whitley(Founder, CEO)in

Co-investorsCOCompanion Fund

Varda industrializes low Earth orbit by manufacturing pharmaceuticals and other specialized products in space, then returning them to Earth via reusable reentry capsules.

BiotechDeep TechSpace TechEl Segundo, US

WBWill Bruey(Founder)inDADelian Asparouhov(Founder)inDaniel Marshall(Founder)Trae Stephens(Director)Josh Wolfe(Director)

Co-investorsALAlso CapitalCACaffeinated CapitalFOFounders FundGEGeneral CatalystKHKhosla VenturesLULux Capital+37 more